Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Inmune Bio, Inc. on June 1, 2022. The company is incorporated in Nevada and its common stock trades on The NASDAQ Stock Market LLC under the symbol INMB. The registrant is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results and does not contain financial performance data.
Material Changes and Voting Results
The filing details the outcomes of two proposals submitted to security holders:
- Proposal One: Election of Directors
- All six nominees were elected to the Board of Directors.
- Edgardo Baracchini, PhD: 2,910,360 votes for; 789,191 withheld.
- J. Kelly Ganjei: 2,891,019 votes for; 808,532 withheld.
- Scott Juda, JD: 3,202,190 votes for; 497,361 withheld.
- Tim Schroeder: 3,192,753 votes for; 506,798 withheld.
- Raymond J. Tesi, MD: 3,182,211 votes for; 517,340 withheld.
- Marcia Allen: 2,903,671 votes for; 795,880 withheld.
- Broker Non-Votes: 5,936,196 shares were recorded as broker non-votes for all director nominees.
- Proposal Two: Ratification of Independent Auditor
- Stockholders approved the appointment of Marcum LLP as the independent auditor for the fiscal year ending December 31, 2022.
- Votes For: 8,806,098
- Votes Against: 12,909
- Abstentions: 816,740
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of the stockholder vote results.
Investor Verification Checklist
- Verify the composition of the newly elected Board of Directors against the company's latest proxy statement.
- Confirm the engagement of Marcum LLP as the independent auditor for the 2022 fiscal year.
- Review the significant number of broker non-votes (5,936,196) regarding the director elections to understand voting power distribution.
- Check subsequent filings (e.g., 10-K or 10-Q) for the financial metrics absent in this 8-K.